Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020378

« Back to Dashboard

NDA 020378 describes GONAL-F, which is a drug marketed by Emd Serono and is included in three NDAs. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the GONAL-F profile page.

The generic ingredient in GONAL-F is follitropin alfa/beta. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the follitropin alfa/beta profile page.

Summary for 020378

Tradename:	GONAL-F
Applicant:	Emd Serono
Ingredient:	follitropin alfa/beta
Patents:	1
Formulation / Manufacturing:	see details

Suppliers and Packaging for NDA: 020378

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378	NDA	EMD Serono, Inc.	44087-9030	N	44087-9030-1
GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378	NDA	EMD Serono, Inc.	44087-9070	N	44087-9070-1

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;SUBCUTANEOUS			Strength	75 IU/VIAL
Approval Date:	Sep 29, 1997	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;SUBCUTANEOUS			Strength	150 IU/VIAL
Approval Date:	Sep 29, 1997	TE:		RLD:	No

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;SUBCUTANEOUS			Strength	37.5 IU/VIAL
Approval Date:	May 25, 2000	TE:		RLD:	No

Expired US Patents for NDA 020378

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-001	Sep 29, 1997	➤ Sign Up	➤ Sign Up
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-002	Sep 29, 1997	➤ Sign Up	➤ Sign Up
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-005	Mar 26, 2004	➤ Sign Up	➤ Sign Up
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-003	May 25, 2000	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.